article thumbnail

U.S. FDA Clears Avita Medical’s Cohealyx for Healing Full-thickness Wounds

The Dermatology Digest

Branded by AVITA Medical and co-developed with Regenity Biosciences, Cohealyx may reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. AVITA Medical plans to develop clinical data for Cohealyx in early 2025 to build on the preclinical success and support the products commercial launch.

article thumbnail

Expanding Innovation and Education in Medical Aesthetics

Dermatology Times

Bob Rhatigan, CEO of Merz Aesthetics, discusses the company’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PHysicians & the esthetician

Southeastern Esthetics Institute

Estheticians and consumers alike understand the advanced changes that can be made within a medical setting - and physicians are realizing the supportive role that Estheticians can bring to their practices. Working in a medical setting as an Esthetician can be both rewarding and beneficial for both yourself and your clients alike.

article thumbnail

Dr Godfrey Town Ph.D re-Certifies as Laser Protection Adviser

Online Laser Training

Our Online Laser Training International Programme Director, Dr Godfrey Town has been re-certified from 1st May 2023 by RPA 2000 for a further five years to act as a Laser Protection Adviser (LPA) and Dr Town holds this for medical, research and teaching.

article thumbnail

Tiger Aesthetics Acquires Several Suneva Medical Product Lines Including BellaFill

The Dermatology Digest

Tiger Aesthetics Medical, LLC, has bought select assets from Suneva Medical, Inc. All across the world, there is growing demand for regenerative treatments that deliver natural and impactful results,” adds Pat Altavilla, CEO of Suneva Medical.

Medical 36
article thumbnail

Dr. Suzan Obagi Named First-ever Chief Medical Director at Obagi Cosmeceuticals

The Dermatology Digest

Suzan Obagi, MD, is Obagi Cosmeceuticals LLC’s first-ever Chief Medical Director. In her role of Chief Medical Director, Dr. Obagi will help shape Obagi’s product development, portfolio refinement, research initiatives, and educational programs. “I Obagi is a subsidiary of Waldencast plc.

Medical 36
article thumbnail

FDA Approves JUVÉDERM VOLUMA XC for Filling Temple Hollows

The Dermatology Digest

The Allergan Medical Institute (AMI) team can train aesthetic providers on safe and effective treatments using the Allergan Aesthetics portfolio to address 90% of the face.